Comparative Clinical Study of Unani Formulations in the Management of Abnormal Vaginal Discharge
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: N899- Noninflammatory disorder of vagina, unspecifiedHealth Condition 2: N898- Other specified noninflammatory disorders of vagina
- Registration Number
- CTRI/2024/08/072386
- Lead Sponsor
- State Takmeel Uttib College And Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Married women above the age of 18 years with regular menstrual cycle
Complain of vaginal discharge associated with low backache lower abdominal pain
and vulvae itching
? Positive Amsel’s criteria
Exclusion Criteria
Pregnant, lactating and menopausal women
Women on antibiotics and hormones in present and recent past
Women with IUCDs
Women with other pelvic pathology STDs genital prolapse and unhealthy cervix
Women with known history of systemic and endocrinal diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Unani formulations' efficacy in treating bacterial vaginosis (N898/N899)?
How do Unani formulations compare to metronidazole or clindamycin in managing bacterial vaginosis (N898/N899)?
Are there specific biomarkers that predict response to Unani formulations in noninflammatory vaginal disorders (N898/N899)?
What adverse events are associated with Unani formulations for bacterial vaginosis (N898/N899) and how are they managed?
What are the potential synergies between Unani formulations and probiotics in treating bacterial vaginosis (N898/N899)?